Deuterium Depleted Water Inhibits the Proliferation of Human MCF7 Breast Cancer Cell Lines by Inducing Cell Cycle Arrest

References

• Sims AH, Ong KR, Harvie MN, Evans DG and Clarke RB: Mechanisms of disease: prediction and prevention of breast cancer–cellular and molecular interactions. Nat Rev Clin Oncol 2, 635–646, 2005.
   Web of Science ®Google Scholar
• Varangot M, Barrios E, Sóñora C, Aizen B, Pressa C, et al.: Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer. Oncol Rep 14, 537–546, 2005.
   PubMed Web of Science ®Google Scholar
• Futreal PA, Wooster R and Stratton MR: Somatic mutations in human cancer: insights from resequencing the protein kinase gene family. Cold Spring Harb Symp Quant Biol 70, 43–49, 2005.
   PubMedGoogle Scholar
• Kim YA, Van Cott EM, Lewandrowski KB, and Lucien FA: The use of decision analysis tools for the selection of clinical laboratory tests: Developing diagnostic and forecasting models using laboratory evidence. In: Evidence Based Pathology and Laboratory Medicine, Marchevsky AM and Wick M (eds.). New York: Springer-Verlag, 2011, pp. 305–322.
   Google Scholar
• Friedenreich CM: Physical activity and breast cancer: review of the epidemiologic evidence and biologic mechanisms. Recent Results Cancer Res 188, 125–139, 2010.
   Google Scholar
• Holohan C, Van Schaeybroeck S, Longley DB and Johnston PG: Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 13, 714–726, 2013.
   PubMed Web of Science ®Google Scholar
• Ahmed MK: Tumor markers of breast cancer: new prospectives. J Oncol Sci 3, 5–11, 2017.
   Google Scholar
• Curreri AR, Ansfield FJ, McIver FA, Waisman HA, Heidelberger C, et al.: Clinical studies with 5-fluorouracil. Cancer Res 18, 478–484, 1958.
   PubMed Web of Science ®Google Scholar
• Berrada M, Yang Z and Lehnert S: Tumor treatment by sustained intratumoral release of 5-fluorouracil: effects of drug alone and in combined treatments. Inter J Radiat Oncol Biol 54, 1550–1557, 2002.
   PubMed Web of Science ®Google Scholar
• Janelsins MC, Kohli S, Mohile SG, Usuki K, Ahles TA, et al.: An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol 38, 431–438, 2011.
   PubMed Web of Science ®Google Scholar
• Ahles TA, Saykin AJ, McDonald BC, Li Y, Furstenberg CT, et al.: Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 28, 4434–4440, 2010.
   PubMed Web of Science ®Google Scholar
• Ahles TA and Saykin A: Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Invest 19, 812–820, 2001.
   PubMed Web of Science ®Google Scholar
• Wefel JS, Vardy J, Ahles T, and Schagen SB: International cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12, 703–708, 2011.
   PubMed Web of Science ®Google Scholar
• Wieneke MH and Dienst ER: Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncol 4, 61–66, 1995.
   Web of Science ®Google Scholar
• Wagner LI, Sweet J, Butt Z, Lai JS, and Cella D: Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy-cognitive function instrument. J Support Oncol 7, 32–39, 2009.
   Google Scholar
• van Dam FS, Schagen SB, Muller MJ, Boogerd W, Vd Wall E, et al.: Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90, 210–218, 1998.
   PubMed Web of Science ®Google Scholar
• Schagen SB, van Dam FS, Muller MJ, Boogerd W, Lindeboom J, et al.: Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85, 640–650, 1999.
   PubMed Web of Science ®Google Scholar
• Morrow GR, Shelke AR, Roscoe JA, Hickok JT, Mustian K, et al.: Management of cancer-related fatigue. Cancer Invest 23, 229–239, 2005.
   PubMed Web of Science ®Google Scholar
• Mustian KM, Peppone LJ, Palesh OG, et al.: Exercise and cancer-related fatigue. US Oncol 6, 20–23, 2010.
   Google Scholar
• Fan HGM, Houédé-Tchen N, Yi Q-L, Chemerynsky I, Downie FP, et al.: Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol 23, 8025–8032, 2005.
   PubMed Web of Science ®Google Scholar
• Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, et al.: Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol 28, 292–298, 2010.
   PubMed Web of Science ®Google Scholar
• Baum M, Buzdar A, Cuzick J, Forbes J, Houghton J, et al.: Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer 98, 1802–1810, 2003.
   PubMed Web of Science ®Google Scholar
• Coates AS, Keshaviah A, Thürlimann B, Mouridsen H, Mauriac L, et al.: Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. J Clin Oncol 25, 486–492, 2007.
   PubMed Web of Science ®Google Scholar
• BIG 1-98 Collaborative Group, Mouridsen H, Giobbie-Hurder A, Goldhirsch A, Thürlimann B, Paridaens R, et al.: Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. N Engl J Med 361, 766–776, 2009.
   PubMed Web of Science ®Google Scholar
• Diller L, Chow EJ, Gurney JG, Hudson MM, Kadin-Lottick NS, et al.: Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. J Clin Oncol 27, 2339–2355, 2009.
   PubMed Web of Science ®Google Scholar
• Mertens AC, Yasui Y, Neglia JP, Potter JD, Nesbit ME, et al.: Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol 19, 3163–3172, 2001.
   PubMed Web of Science ®Google Scholar
• Chen Z, Maricic M, Pettinger M, Ritenbaugh C, Lopez AM, et al.: Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer. Cancer 104, 1520–1530, 2005.
   PubMed Web of Science ®Google Scholar
• Twiss JJ, Waltman N, Ott CD, Gross GJ, Lindsey AM, et al.: Bone mineral density in postmenopausal breast cancer survivors. J Am Acad Nurse Pract 13, 276–284, 2001.
   PubMedGoogle Scholar
• Reid-Arndt SA, Yee A, Perry MC and Hsieh C: Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors. J Psychosoc Oncol 27, 415–434, 2009.
   PubMed Web of Science ®Google Scholar
• Ma AMT, Barone J, Wallis AE, Wu NJ, Garcia LB, et al.: Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients. Am J Surg 196, 500–504, 2008.
   PubMed Web of Science ®Google Scholar
• Olariu L, Petcu M, Tulcan C, et al.: Deuterium depleted water–antioxidant or prooxidant. J Vet Med Sci 15, 265–269, 2007.
   Google Scholar
• Soleyman-Jahi S, Zendehdel K, Akbarzadeh K, Haddadi M, Amanpour S and Muhammadnejad S: In vitro assessment of antineoplastic effects of deuterium depleted water. Asian Pac J Cancer Prev 15, 2179–2183, 2014.
   PubMedGoogle Scholar
• Cong F-S, Zhang Y-R, Sheng H-C, Ao Z-H, Zhang S-Y, et al.: Deuterium-depleted water inhibits human lung carcinoma cell growth by apoptosis. Exp Ther Med 1, 277–283, 2010.
   PubMed Web of Science ®Google Scholar
• Somlyai G, Laskay G, Berkenyi T, Galbacs Z, Galbacs G, et al.: The biological effects of deuterium-depleted water, a possible new tool in cancer therapy. Oncology 30, 91–94, 1998.
   Google Scholar
• Gyöngyi Z, Budán F, Szabó I, Ember I, Kiss I, et al.: Deuterium depleted water effects on survival of lung cancer patients and expression of Kras, Bcl2, and Myc genes in mouse lung. Nutr Cancer 65, 240–246, 2013.
   PubMed Web of Science ®Google Scholar
• Boros LG, D’Agostino DP, Katz HE, Roth JP, Meuillet EJ, et al.: Submolecular regulation of cell transformation by deuterium depleting water exchange reactions in the tricarboxylic acid substrate cycle. Med Hypotheses 87, 69–74, 2016.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, et al.: Global cancer statistics, 2012. CA Cancer J Clin 65, 87–108, 2015.
   PubMed Web of Science ®Google Scholar
• Ganz PA, Kwan L, Stanton AL, Krupnick JL, Rowland JH, et al.: Quality of life at the end of primary treatment of breast cancer, first results from the moving beyond cancer randomized trial. J Natl Cancer Inst 96, 376–387, 2004.
   PubMed Web of Science ®Google Scholar
• Essen CFV: Biological effects of deuterium. Yale J Biol Med 37, 99, 1964.
   Google Scholar
• Somlyai G, Jancsó G, Jákli G, Vass K, Barna B, et al.: Naturally occurring deuterium is essential for the normal growth rate of cells. FEBS Lett 317, 1–4, 1993.
   PubMed Web of Science ®Google Scholar
• Somlyai G, Molnár M, Laskay G, Szabó M, Berkényi T, et al .: Biological significance of naturally occurring deuterium: the antitumor effect of deuterium depletion. Orv Hetil 151, 1455–1460, 2010.
   PubMedGoogle Scholar
• Cong F-S, Zhan Y-R, Sheng H-C, Ao Z-H, Zhan S-Y, et al.: Deuterium-depleted water inhibits human lung carcinoma cell growth by apoptosis. Exp Ther Med 1, 277–283, 2010.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhu B, Liu C, Fang W and Yang H: Deuterium-depleted water selectively inhibits nasopharyngeal carcinoma cell proliferation in vitro. South Med J 32, 1394–1399, 2012.
   Google Scholar
• Kovacs A, Guller I, Krempels K, et al. Deuterium depletion may delay the progression of prostate cancer. J Cancer Ther 2, 548–556, 2011.
   Google Scholar
• Somlyai G: Deuterium depletion and its impact on life expectancy of patients with stage IV breast tumor. J Compl Alt Med 8, 30–35, 2004.
   Google Scholar
• Krempels K, Somlyai I and Somlyai G: A retrospective evaluation of the effects of deuterium depleted water consumption on 4 patients with brain metastases from lung cancer. Integr Cancer Ther 7, 172–181, 2008.
   PubMed Web of Science ®Google Scholar
• Longley DB, Harkin DP, and Johnston PG : 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3, 330–338, 2003.
   PubMed Web of Science ®Google Scholar
• Zhang N, Yin Y, Xu S-J, and Chen W-S: 5-Fluorouracil, mechanisms of resistance and reversal strategies. Molecules 13, 1551–1569, 2008.
   PubMed Web of Science ®Google Scholar
• Laskay G, Somlyai G, Jancsó G, and Jákli G: Reduced deuterium concentration of water stimulates o2-uptake and electrogenic H+-efflux in the aquatic macrophyte Elodea canadensis. Jpn J Deuterim Sci 10, 17–23, 2001.
   Google Scholar
• Berdea P, Cuna S, Cazacu M, and Tudose M: Deuterium variation of human blood serum. Stud Univ Babes Bolya Phys 1, 256–258, 2001.
   Google Scholar
• Valko M, Rhodes C, Moncol J, Izakovic M and Mazur M: Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Intergr 160, 1–40, 2006.
   PubMed Web of Science ®Google Scholar
• Spitz DR, Sim JE, Ridnour LA, Galoforo SS, and Lee YJ: Glucose deprivation‐induced oxidative stress in human tumor cells, a fundamental defect in metabolism. Ann NY Acad Sci 899, 349–362, 2006.
   Web of Science ®Google Scholar
• Xu Y, Xin Y, Diao Y, Lu C, Fu J, et al.: Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells. PLoS One 6, e29169, 2011.
   PubMed Web of Science ®Google Scholar
• Harris AL: Hypoxia: a key regulatory factor in tumour growth. Nat Rev Cancer 2, 38–47, 2002.
   PubMed Web of Science ®Google Scholar
• Yavari K and Gholamali M: Yazdian: Decreasing of deuterium concentration of water: a possible tool in diabetes therapy. Electron J Biol 13, 314–319, 2017.
   Google Scholar
• Basov AA, Baryshev МG, Dzhimak SS, and Bykov I: Sepiashvili Pavliuchenko MI: the effect of consumption of water with modified isotope content on the parameters of free radical oxidation in vivo. Fiziol Zh 59, 50–57, 2013.
   Google Scholar
• Dzhimak SS, Basov AA, Fedulova LV, Didikin AS, Bikov IM, et al.: Correction of metabolic processes in rats during chronic endotoxicosis using isotope (D/H) exchange reactions. Biol Bull Russ Acad Sci 42, 440–448, 2015.
   Web of Science ®Google Scholar
• Alexander AK, Stanislav VK, Ekaterina RV, et al.: Effect of drinking ration with reduced deuterium content on brain tissue prooxidant–antioxidant balance in rats with acute hypoxia model. J Pharm Nutr Sci 8, 42–51, 2018.
   Google Scholar
• Sim JE, Ridnour LA, Galoforo SS, and Lee YJ: Glucose deprivation‐induced oxidative stress in human tumor cells, a fundamental defect in metabolism? Ann NY Acad Sci 899, 349–362, 2000.
   PubMed Web of Science ®Google Scholar